Plaintiffs’ lawyer: At any time when Zantac had been on the market for almost soyears, did Glaxo cause anyone to test for the presence of NDMA, a probable human carcinogen, in the product it was selling to American consumers known as Zantac?
Glaxo senior medical adviser: Not to my knowledge.
—Deposition, June 2021